Literature DB >> 7503071

A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody.

M Fukushima1, Y Tsuchiyama, T Nakato, T Yokoi, H Ikeda, S Yoshida, T Kusumoto, K Itoh, H Sakuraba.   

Abstract

We describe a female patient with heterozygous Fabry's disease. The patient had persistent proteinuria and microhematuria but lacked any other diagnostic signs such as corneal and cutaneous involvement. Kidney tissue obtained at biopsy showed the segmentally distributed enlarged glomerular epithelia. These cells were filled with vacuolated foamy cytoplasm, which had lamellar and myelinoid structures under electronmicroscopic observation. Accumulation of trihexosylceramide (CTH) in these foamy epithelial cells was confirmed with immunohistochemical staining with the use of anti-CTH monoclonal antibody. Alpha-galactosidase activity of leukocytes was 67 nmol/mg protein/hr, which was approximately half that of the normal population (mean +/- SD, 147 +/- 65 nmol/mg protein/hr, n = 20). All of these findings were compatible with the diagnosis of heterozygous Fabry's disease. We recommend that kidney tissue biopsy specimens suggesting Fabry's disease be immunostained with anti-CTH antibody.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503071     DOI: 10.1016/0272-6386(95)90061-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Cellular and tissue localization of globotriaosylceramide in Fabry disease.

Authors:  Hasan Askari; Christine R Kaneski; Cristina Semino-Mora; Priya Desai; Agnes Ang; David E Kleiner; Lorah T Perlee; Martha Quezado; Linda E Spollen; Brandon A Wustman; Raphael Schiffmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes.

Authors:  Fumiko Matsuzawa; Sei-ichi Aikawa; Hirofumi Doi; Toshika Okumiya; Hitoshi Sakuraba
Journal:  Hum Genet       Date:  2005-05-28       Impact factor: 4.132

3.  Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

Authors:  C Whybra; C Kampmann; I Willers; J Davies; B Winchester; J Kriegsmann; K Brühl; A Gal; S Bunge; M Beck
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

4.  Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.

Authors:  Carmen Valbuena; Dina Leitão; Fátima Carneiro; João Paulo Oliveira
Journal:  Virchows Arch       Date:  2011-12-29       Impact factor: 4.064

Review 5.  Fabry's disease: a multidisciplinary disorder.

Authors:  F P Peters; A Sommer; A Vermeulen; E C Cheriex; T L Kho
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

6.  Frequency of Fabry disease in male and female haemodialysis patients in Spain.

Authors:  Paulo Gaspar; Julio Herrera; Daniel Rodrigues; Sebastián Cerezo; Rodrigo Delgado; Carlos F Andrade; Ramón Forascepi; Juan Macias; Maria D del Pino; Maria D Prados; Pilar R de Alegria; Gerardo Torres; Pedro Vidau; Maria C Sá-Miranda
Journal:  BMC Med Genet       Date:  2010-02-01       Impact factor: 2.103

7.  Corrective effect on Fabry mice of yeast recombinant human alpha-galactosidase with N-linked sugar chains suitable for lysosomal delivery.

Authors:  Hitoshi Sakuraba; Yasunori Chiba; Masaharu Kotani; Ikuo Kawashima; Mai Ohsawa; Youichi Tajima; Yuki Takaoka; Yoshifumi Jigami; Hiroshi Takahashi; Yukihiko Hirai; Takashi Shimada; Yasuhiro Hashimoto; Kumiko Ishii; Toshihide Kobayashi; Kazuhiko Watabe; Tomoko Fukushige; Tamotsu Kanzaki
Journal:  J Hum Genet       Date:  2006-03-11       Impact factor: 3.172

8.  Identification and expression analysis of zebrafish glypicans during embryonic development.

Authors:  Mansi Gupta; Michael Brand
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.